Skip to main content

Myelodysplastic Syndromes

Rare

Cancer

Myelodysplastic Syndromes is treated with 1 medication in our database, including Revlimid. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Bristol Myers Squibb. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Myelodysplastic Syndromes treatment below.

What help exists for Myelodysplastic Syndromes

13

drugs indexed

6

with copay cards

6

with patient assistance

19

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Myelodysplastic Syndromes

13 total

🎟 = copay card · 💙 = patient assistance program

Prior authorization patterns for Myelodysplastic Syndromes drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Showing 10 of 21 PA rules for Myelodysplastic Syndromes drugs. View individual drug pages for complete PA detail.

Grants for Myelodysplastic Syndromes patients

25 total · 19 open

Myelodysplastic Syndromes is a rare disease — more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare →